Computer glitch in insulin pumps hits MiniMed shares
This article was originally published in Clinica
Executive Summary
MiniMed has warned that a software error in some of its insulin pumps could lead to unreliable insulin dosing. The company said that only certain of its Model 508 pumps, manufactured between October 4 and November 18, are affected. The fault will cost the company up to $1.5 million to upgrade the relevant software. MiniMed saw more than $10 wiped from its share price on the announcement, with its shares ending early last Tuesday at $79.20.